详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Hua Wang[1] ; Bi-bo Fu[1] ; Zhi-jun Wuxiao[2] ; Ya-jun Li[3] ; Li Huang[4] ; Jie Ma[5] ; Zhi-min Zhai[6] ; Jing Guo[4] ; Yuan-bin Wu[7] ; Zhen-shu Xu[8] ; Jia Feng[9] ; Sheng-sheng Zhou[5] ; Ting-ting Chen[10] ; Xing-gui Chen[11] ; Guo-wei Li[12] ; Ting-zhi Liu[13] ; Hai-bin Huang[14] ; Run-hui Zheng[15] ; Yong-hua Li[16] ; Hong-fang Tao[17] ; Fu-ming Zi[18] ; Fan Wu[6] ; Juan Wang[6] ; Hui Zeng[19] ; Cai-bo Fu[2] ; Robert Peter Gale[1,20] ; Zhong-jun Xia[1] ; Yang Liang[1] ;

机构： [1]Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China. [2]Department of Hematology, Lymphoma and Myeloma Center, HMC Cancer Institute, The First Affiliated Hospital of Hainan Medical University, Haikou City, Hainan, PR China. [3]Department of Lymphoma and Hematology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China. [4]Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, PR China. [5]Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China. [6]Department of Hematology, The Second Hospital of Anhui Medical University, Hefei, Anhui, PR China. [7]Department of Hematology, Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, PR China. [8]Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, PR China. [9]Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China. [10]Department of Hematology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University), Shenzhen, PR China. [11]Cancer Center, Affiliated Hospital, Guangdong Medical University, Zhanjiang, Guangdong, PR China. [12]Department of Hematology, Huizhou Municipal Central Hospital, Huizhou, Guangdong, PR China. [13]Department of Medical Hematology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangdong gastrointestinal hospital, Guangzhou, Guangdong, PR China. [14]Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, PR China. [15]Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China. [16]Department of Hematology, General Hospital of Southern Theater Command, PLA, Guangzhou, Guangdong, PR China. [17]The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, PR China. [18]Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China. [19]Department of Hematology, The First Affiliated Hospital of Jinan university, Guangzhou, Guangdong, PR China. [20]Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.

出处：

DOI：

ISSN：

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区血液学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区血液学 1 区肿瘤学

JCR分区：

出版当年[2022]版：

Q1 HEMATOLOGY Q1 ONCOLOGY

最新[2023]版：

Q1 HEMATOLOGY Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma

文献详情